Published in Arthritis Res Ther on April 02, 2003
HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum (2009) 2.00
Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis. Mod Rheumatol (2011) 1.20
Neurological manifestations of Behçet's disease in Japan: a study of 54 patients. J Neurol (2010) 1.11
Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int (2007) 1.03
Pathophysiology of the Behçet's Disease. Patholog Res Int (2011) 0.94
Proinflammatory cytokines and C-reactive protein in uveitis associated with Behçet's disease. Mediators Inflamm (2014) 0.89
Identification of kinectin as a novel Behçet's disease autoantigen. Arthritis Res Ther (2005) 0.88
Clinical and Pathological Manifestations with Differential Diagnosis in Behçet's Disease. Patholog Res Int (2011) 0.87
Development of Immunopathogenesis Strategies to Treat Behçet's Disease. Patholog Res Int (2012) 0.87
Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features. Orphanet J Rare Dis (2013) 0.84
A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet's disease. Arthritis Rheum (2011) 0.82
Cytokines Modulate the "Immune-Metabolism" Interactions during Behçet Disease: Effect on Arginine Metabolism. Int J Inflam (2015) 0.78
New insights into HLA class I association to Behçet's syndrome in Iranian Azari patients. Auto Immun Highlights (2013) 0.77
The Evaluation of Saliva Flow Rate, pH, Buffer Capacity, Microbiological Content and Indice of Decayed, Missing and Filled Teeth in Behçet's Patients. Balkan Med J (2013) 0.75
The role of CTLA-4 exon-1 49 A/G polymorphism and soluble CTLA-4 protein level in egyptian patients with Behçet's disease. Biomed Res Int (2014) 0.75
Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease. J Immunol Res (2015) 0.75
Syndromes of hearing loss associated with visual loss. Eur Arch Otorhinolaryngol (2013) 0.75
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet (1996) 26.06
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell (1990) 4.84
Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet (2001) 2.95
IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol (2000) 2.93
Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 2.78
Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol (1982) 2.51
Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med (2002) 2.17
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
Behçet's disease and the nervous system. J Neurol (1998) 1.92
Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet (1989) 1.92
Leucocyte movement and colchicine treatment in Behcet's disease. Lancet (1975) 1.83
Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol (2002) 1.74
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet (1999) 1.41
T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol (1993) 1.37
Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan. J Rheumatol (1989) 1.35
Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study. Arch Dermatol (2002) 1.32
Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum (1999) 1.27
Sentinel function of broadly reactive human gamma delta T cells. Immunol Today (1997) 1.27
Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J Immunol (1999) 1.26
Role of gammadelta T lymphocytes in the development of Behçet's disease. Clin Exp Immunol (1997) 1.26
Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report. Gastroenterology (2001) 1.25
Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum (1995) 1.21
Heterogeneity in rates of recombination in the 6-Mb region telomeric to the human major histocompatibility complex. Genomics (1997) 1.20
A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum (2001) 1.20
Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol (1995) 1.19
Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan. Clin Exp Immunol (1997) 1.18
Deep vein thrombosis in Behçet's disease. Clin Exp Rheumatol (2001) 1.14
Abnormal T cell responses to bacterial superantigens in Behçet's disease (BD). Clin Exp Immunol (1998) 1.14
MEFV mutations in Behçet's disease. Hum Mutat (2000) 1.13
Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatol (1996) 1.10
Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease. Histopathology (2000) 1.08
Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab. Rheumatology (Oxford) (2001) 1.06
Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy. Ann Rheum Dis (2001) 1.05
Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol (2002) 1.05
Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's disease. Hum Immunol (1995) 1.04
The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behçet's disease. Int J Dermatol (1998) 1.03
Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum (2001) 1.01
Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol (1999) 1.00
Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome. Clin Immunol Immunopathol (1997) 0.99
Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. Arthritis Rheum (1999) 0.96
IL-8 producing cells in patients with Behçet's disease. Clin Exp Rheumatol (2000) 0.96
Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease. J Neurol Sci (1998) 0.95
Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease. Cell Immunol (1992) 0.95
Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients. Tissue Antigens (1999) 0.92
Peripheral blood T cell expansions in patients with Behcet's disease. Clin Exp Immunol (1997) 0.92
Oligoclonal T cell expansions in patients with Behçet's disease. Clin Exp Immunol (1999) 0.92
HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet's disease. Tissue Antigens (2001) 0.91
Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel. Ann Rheum Dis (2002) 0.89
Behçet's disease in UK children: clinical features and treatment including thalidomide. Rheumatology (Oxford) (2001) 0.89
Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels. Clin Immunol (1999) 0.86
Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology (1999) 0.84
V gamma gene usage in peripheral blood gamma delta T cells. Immunol Lett (1993) 0.83
Linkage mapping of a novel susceptibility locus for Behçet's disease to chromosome 6p22-23. Arthritis Rheum (2001) 0.82
The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease. Tissue Antigens (2001) 0.82
Cerebrospinal fluid beta(2)-microglobulin in neuro-Behçet's syndrome. J Neurol Sci (2000) 0.81
An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res (2009) 2.69
HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int J Cancer (2009) 1.54
Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. Cancer Res (2007) 1.33
Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis. Cancer Res (2006) 1.31
Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability. Gastroenterology (2009) 1.30
Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis. Mod Rheumatol (2011) 1.20
TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res (2008) 1.18
Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. Endocr Relat Cancer (2008) 1.11
Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res (2006) 0.99
Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice. J Immunol (2005) 0.98
Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells. PLoS One (2010) 0.97
Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain (2013) 0.95
Mesenteric paraganglioma: Report of a case. World J Gastrointest Surg (2013) 0.95
Microarray analysis identifies versican and CD9 as potent prognostic markers in gastric gastrointestinal stromal tumors. Cancer Sci (2011) 0.92
Bone marrow CD34+ progenitor cells stimulated with stem cell factor and GM-CSF have the capacity to activate IgD- B cells through direct cellular interaction. J Leukoc Biol (2002) 0.90
TSU68, an antiangiogenic receptor tyrosine kinase inhibitor, induces tumor vascular normalization in a human cancer xenograft nude mouse model. Surg Today (2009) 0.89
Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts. Int J Cancer (2014) 0.86
Effect of miR-122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis. Cancer Sci (2013) 0.86
Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study. Medicine (Baltimore) (2016) 0.83
Optical diagnosis of gastric cancer using near-infrared multichannel Raman spectroscopy with a 1064-nm excitation wavelength. J Gastroenterol (2008) 0.83
Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth. Gastroenterology (2008) 0.83
Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease. Intern Med (2012) 0.82
Near-infrared multichannel Raman spectroscopy with a 1064 nm excitation wavelength for ex vivo diagnosis of gastric cancer. J Surg Res (2011) 0.82
HLA-B51 and cigarette smoking as risk factors for chronic progressive neurological manifestations in Behçet's disease. Mod Rheumatol (2007) 0.81
Usefulness of three-dimensional angiographic analysis of perigastric vessels before laparoscopic gastrectomy. Gastric Cancer (2012) 0.81
Is the long-term use of systemic corticosteroids beneficial in the management of Behçet's syndrome? Nat Clin Pract Rheumatol (2006) 0.81
Regulation of human B cell function by sulfasalazine and its metabolites. Int Immunopharmacol (2002) 0.79
Analysis of membrane antigens on neutrophils from patients with sepsis. J Infect Chemother (2012) 0.78
Adrenomedullin is a therapeutic target in colorectal cancer. Int J Cancer (2013) 0.76
Oncogenic KRAS regulates BMP4 expression in colon cancer cell lines. Am J Physiol Gastrointest Liver Physiol (2012) 0.75
Three-dimensional fusion images combining CT gastrography and CT angiography for early gastric cancer: pilot experiences of preoperative simulation prior to totally laparoscopic gastrectomy. Asian J Endosc Surg (2015) 0.75
[A case of gastric GIST treated preoperatively by imatinib mesylate]. Gan To Kagaku Ryoho (2004) 0.75
Rapid assay for detecting gyrA and parC mutations associated with fluoroquinolone resistance in Enterobacteriaceae. J Microbiol Methods (2013) 0.75
Histopathological analysis of cerebral hemorrhage in systemic lupus erythematosus complicated with antiphospholipid syndrome. Mod Rheumatol (2011) 0.75
GIST: The current state of molecular target therapy. Nihon Shokakibyo Gakkai Zasshi (2011) 0.75
Pancreatoduodenal artery aneurysm resulting from median arcuate ligament compression successfully treated with laparoscopic ligament section. Asian J Endosc Surg (2014) 0.75
[Case of rheumatic fever complicating carditis detected by a newly-developed systolic murmur in an adult woman]. Nihon Rinsho Meneki Gakkai Kaishi (2012) 0.75
Churg-Strauss syndrome complicated by central retinal artery occlusion: case report and a review of the literature. Mod Rheumatol (2011) 0.75
Effects of erythromycin and rifampicin on immunomodulatory gene expression and cellular function in human polymorphonuclear leukocytes. Chemotherapy (2014) 0.75
Relapsing Polychondritis Complicated by Vasculitis of the Omentum. Intern Med (2016) 0.75
Analysis of various factors on the relapse of acute neurological attacks in Behçet's disease. Mod Rheumatol (2014) 0.75